Eli Lilly Talks Up Emerging Markets, Especially China, As One Salve For Its Problems

Insisting they are not playing catch up overseas, Eli Lilly executives outlined plans for growing their business in the so-called emerging markets that are now a hot terrain - and a familiar phrase - among the biggest drug makers